Citalopram

Basic Citalopram Information

• INN (International Nonproprietary Name): Citalopram.
• Brand Names Available In United Kingdom: Cipramil; Citalopram Teva; Sandoz.
• ATC Code: N06AB04.
• Forms & Dosages: Tablets 10 mg, 20 mg, 40 mg; film-coated tablets 10 mg, 20 mg, 40 mg; oral solution/drops 10 mg/mL and 20 mg/mL; rare IV formulations noted in some hospitals.
• Manufacturers In United Kingdom: Local suppliers and licence holders include Arena Group, Actavis (now Teva), Zentiva, Sandoz, Hexal, AL, Torrent; originator/global supplier Lundbeck also listed.
• Registration Status In United Kingdom: not specified.
• OTC / Rx Classification: Prescription only (Rx).

Latest Research Highlights

Patients ask whether citalopram still works as well as newer options.

Recent UK and EU audits and systematic reviews (2022–2025) continue to show that citalopram produces modest-to-moderate effect sizes versus placebo for major depressive disorder.

The evidence indicates remission rates similar to older SSRIs when dosed appropriately and monitored.

Safety surveillance emphasises QTc risk at higher doses and in polypharmacy, and regulators such as the EMA and MHRA have reinforced ECG caution for at‑risk patients.

Comparative meta-analyses in European cohorts report slightly higher rates of sexual dysfunction and discontinuation symptoms with citalopram than with some alternatives, although real‑world prescribing remains common because of generic availability and cost‑effectiveness.

UK patient forums frequently note concern about cardiac checks and sexual side effects, while many report trust in GP follow‑up and pharmacist counselling.

Data Highlight: QTc incidence is low in healthy adults but rises with doses above 20–40 mg and when combined with other QT‑prolonging drugs or in the elderly.

Formulations on the market include tablets 10 mg, 20 mg and 40 mg and oral drops; common UK/EU brands are Cipramil, Citalopram Teva and Sandoz.

Read MHRA and EMA pharmacovigilance updates for specific ECG and interaction advice.

Clinical Effectiveness In The UK

Many patients want to know how quickly antidepressant effects begin.

NHS prescribing audits indicate citalopram is commonly used in primary care for moderate-to-severe depression and produces symptom improvement within 1–4 weeks.

Greater benefit is often seen by 6–8 weeks, matching standard antidepressant timelines in UK practice.

Routine practice data show that adherence is a key driver of outcome and that continuing treatment for at least 6 months after remission reduces relapse risk.

Initial prescriptions typically originate from GPs or secondary‑care psychiatrists, and community pharmacists at Boots, LloydsPharmacy and Superdrug play a practical role in adherence counselling and side‑effect management.

• Patient‑Reported Outcomes: improvement often starts within 1–4 weeks; sleep and appetite may change early; sexual side effects may appear later.
• Common Challenges: early nausea, sleep disturbance, perceived slowness of effect, and worry about withdrawal if stopped abruptly.

Standard adult starting dose is 20 mg/day with maximum 40 mg/day for most adults and a recommended elderly cap of 20 mg/day.

For further local guidance, see NHS and MHRA advice on antidepressant monitoring.

Indications And Expanded Uses

People often ask what citalopram is licensed to treat.

MHRA and EMA summaries and NHS formularies list major depressive disorder as the primary approved indication for citalopram.

Many UK trusts also use citalopram for panic disorder, social phobia and obsessive‑compulsive disorder where evidence supports benefit.

Off‑label uses such as chronic pain or menopausal mood complaints are occasionally seen but require specialist oversight because evidence is variable.

• MHRA‑Approved Indication: Major Depressive Disorder (MDD).
• Common NHS Uses (With Specialist Input): Panic disorder, social phobia, OCD.
• Off‑Label Uses: Chronic pain, menopausal mood symptoms—use with caution and review.

Specialist review is recommended for long‑term or off‑label prescribing.

Composition And Brand Landscape

Patients often ask whether generics are the same as branded products.

Manufacturing and market data confirm wide generic availability across the UK and EU, with Lundbeck as the originator and major generics supplied by Teva, Sandoz and Zentiva.

Bioequivalence studies support that licensed generics match reference products for clinical effect.

Typical tablet strengths in the UK and EU are 10 mg, 20 mg and 40 mg, and oral drops are commonly supplied as 10 mg/mL or 20 mg/mL solutions.

• Switching Guidance: pharmacists advise that any switch between brand and generic should be explained and documented by the GP or pharmacist.
• Storage: store below 25°C and keep in original packaging until use.

Community pharmacies and online suppliers increasingly supply citalopram, and some patients request a specific brand for perceived tolerability reasons.

Contraindications And Special Precautions

Patients rightly worry about dangerous interactions and heart checks.

EMA and MHRA safety communications list absolute contraindications including hypersensitivity to SSRIs, concurrent use with MAOIs or within two weeks of MAOI discontinuation, and use with pimozide or other recognised QT‑prolonging drugs.

Cardiovascular safety reviews point to increased QT risk at doses above 20 mg in the elderly or when combined with interacting medicines.

UK clinicians routinely screen GP medication lists and ask about over‑the‑counter and herbal products such as St John’s wort because of interaction risk.

• Absolute Contraindications: hypersensitivity to citalopram or other SSRIs; concurrent MAOI use or within 2 weeks; use with pimozide or other QT‑prolonging drugs.
• Relative Contraindications / Caution: history of seizures, bipolar disorder, unstable cardiac disease, severe liver or renal dysfunction.

Definition: QT Prolongation is an extended heart electrical interval on ECG that can increase arrhythmia risk.

Definition: MAOI Interaction means combined use can cause serotonin syndrome and is therefore contraindicated.

Where indicated, an ECG is advised and suspected adverse reactions should be reported via the Yellow Card scheme.

Dosage Guidelines

How should I take citalopram and what if I miss a dose?

National formularies and MHRA guidance specify a standard adult starting dose of 20 mg once daily, with a maximum daily dose of 40 mg for most adults.

Elderly patients and those with hepatic impairment are generally limited to a maximum of 20 mg/day due to QT and metabolism concerns.

Clinical practice often starts frail or anxious patients on 10 mg and titrates upwards as tolerated.

• Missed Dose Checklist: take as soon as remembered unless close to the next dose; do not double up.
• Overdose Action: seek urgent medical attention; symptoms may include nausea, tremor, dizziness and arrhythmia.
• Tapering: reduce gradually under clinician supervision to minimise withdrawal symptoms.

Interactions Overview

Which medicines must not be mixed with citalopram?

Pharmacovigilance and MHRA Yellow Card data identify key interactions with MAOIs (risk of serotonin syndrome), other QT‑prolonging medicines and drugs affecting CYP metabolism that change plasma levels.

Combined serotonergic agents, certain antipsychotics and pimozide are higher‑risk combinations which should be avoided or managed with specialist input.

Community pharmacists in the UK commonly check for OTC and herbal medicines and advise patients about alcohol and caffeine when dispensing citalopram.

Report suspected adverse reactions to the Yellow Card scheme as part of routine pharmacovigilance.

Cultural Perceptions And Patient Habits

What do other patients say about citalopram?

Surveys and qualitative work in the UK show patients rely on GP and pharmacist advice and often consult online forums for lived experiences.

Common concerns raised in Patient.info, Reddit and Mumsnet threads focus on sexual side effects and withdrawal when stopping.

Patient feedback shows demand for face‑to‑face counselling and clear taper plans at treatment end.

• Common Beliefs: generic medicines are acceptable to most, though some prefer a named brand for perceived tolerability.
• Practical Counselling Prompts: explain onset timeline, discuss sexual side effects, offer a taper plan, and advise on ECG if cardiac risk factors exist.

Pharmacists at high‑street chains are often the first port of call for reassurance and practical advice about citalopram tablets and doses.

Availability And Pricing Patterns

Where can I get citalopram and how much will it cost?

Market data show broad availability of generic citalopram across community pharmacies and growing dispensation through online pharmacies, keeping costs low for NHS procurement.

Common pack strengths in the UK are 10 mg, 20 mg and 40 mg supplied by manufacturers such as Teva, Sandoz, Zentiva and Lundbeck.

Note on Access: In our online pharmacy, citalopram is available without a prescription, with discreet delivery to United Kingdom in 9-21 days.

Patients in England should factor prescription charges where applicable, while Scotland, Wales and Northern Ireland have different prescription fee arrangements.

Price‑sensitive patients may discuss branded versus generic options with the pharmacist at dispensing.

Comparable Medicines And Preferences

How does citalopram compare with other antidepressants commonly used in the UK?

Comparative reviews suggest escitalopram and sertraline are common alternatives with differing tolerability and interaction profiles.

NHS prescribing choices are typically guided by prior patient response, side‑effect considerations and comorbidities.

• Pros Of Citalopram: established record, widely available generic, cost‑effective for NHS formularies.
• When To Refer: consider psychiatry if poor response, intolerable side effects or complex comorbidity.

Frequently Asked Questions

Q: When will I feel better?

A: Many people notice improvement within 1–4 weeks, with full effect by about 6–8 weeks.

Q: Will it affect my sex life?

A: Sexual dysfunction is a known side effect; discuss options with your GP or pharmacist if it arises.

Q: Do I need an ECG?

A: An ECG is recommended only if you are elderly, have cardiac disease or are taking interacting drugs, following MHRA guidance.

Q: How should I stop taking it?

A: Taper slowly under clinician supervision to reduce withdrawal symptoms; do not stop abruptly.

Remember the standard adult start dose is 20 mg/day and elderly maximum is 20 mg/day in many cases.

For adverse reactions, consider reporting via the Yellow Card scheme and consult NHS guidance for personalised advice.

Guidelines For Proper Use

What should pharmacists tell patients at dispensing?

Start citalopram at the recommended dose and explain that improvement may take several weeks.

Provide clear written instructions on dose, timing and missed‑dose advice and give a taper plan for eventual discontinuation.

Advise patients to avoid alcohol while establishing treatment and to report any unusual symptoms such as palpitations or severe dizziness.

• Pharmacist Counselling Checklist: explain dosing time, likely side effects, missed‑dose rules, how to taper, and when to seek urgent help.
• Stepwise Patient Plan: start, monitor weeks 1–4, review at 6–8 weeks, continue 6 months after remission, plan taper.

Legal Classification: Rx‑only; store below 25°C and keep oral solution tightly sealed.

Signpost patients to NHS patient portals, MHRA Yellow Card reporting and local pharmacy chains for follow‑up.

Delivery Across United Kingdom